Gilead Sciences, Inc. (NASDAQ:GILD)
CAPS Rating:
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
Recs
bought two months ago at 46.96 and forgot to log it here. Bought primarily due to SA recommendation